Cargando…

LB761 Clinical outcomes in Pemphigoid and Pemphigus patients with COVID-19

Detalles Bibliográficos
Autores principales:	Pakhchanian, H., Raiker, R., Wang, J., Phan, K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374137/ http://dx.doi.org/10.1016/j.jid.2021.07.103

Ejemplares similares

LB751 COVID-19 complications in patients with Hidradenitis Suppurativa: A multicenter study
por: Raiker, R., et al.
Publicado: (2021)

LB768 Adult and pediatric emergency department visits for dermatological conditions during the COVID-19 pandemic: A multicenter analysis
por: Pakhchanian, H., et al.
Publicado: (2021)

LB767 A multicenter analysis of patients using telemedicine for dermatological conditions during the COVID-19 pandemic
por: Raiker, R., et al.
Publicado: (2021)

LB766 Prevalence and adverse events of special interest among COVID19-vaccinated patients with chronic inflammatory skin diseases: An early look
por: Raiker, R., et al.
Publicado: (2021)

342 Clinical outcomes in COVID-19 patients with Atopic dermatitis
por: Pakhchanian, H., et al.
Publicado: (2021)

338 Clinical outcomes in COVID-19 patients with dermatopolymyositis
por: Pakhchanian, H., et al.
Publicado: (2021)

Current Clinical Trials in Pemphigus and Pemphigoid
por: Izumi, Kentaro, et al.
Publicado: (2019)

243 Clinical outcomes in COVID-19 patients with varicella zoster virus
por: Raiker, R., et al.
Publicado: (2021)

254 COVID-19 related outcomes in psoriasis and psoriasis arthritis patients
por: Raiker, R., et al.
Publicado: (2021)

HERPETIFORM PEMPHIGUS CLINICALLY RESEMBLING BULLOUS PEMPHIGOID
por: Mehta, Vandana, et al.
Publicado: (2008)

Milestones in Personalized Medicine in Pemphigus and Pemphigoid
por: Bieber, Katja, et al.
Publicado: (2021)

Incidence of Bullous Pemphigoid and Pemphigus in Korea
por: Joo, Jae Seong, et al.
Publicado: (2021)

Reply to “Letter to the Editor Regarding ‘COVID-19 outcomes in patients with Dermatomyositis: A registry-based cohort analysis’”
por: Pakhchanian, H, et al.
Publicado: (2023)

205 COVID-19 complications in vitiligo patients: A multicenter study
por: Raiker, R., et al.
Publicado: (2022)

262 Safety and efficacy of the COVID-19 vaccine among fully vaccinated and boosted skin cancer patients
por: Raiker, R., et al.
Publicado: (2022)

331 Trends and outcomes in patients with malignant skin cancers during the COVID pandemic
por: Raiker, R., et al.
Publicado: (2021)

35309 COVID-19 outcomes among patients with cutaneous T-cell lymphoma: A multicentered analysis
por: Baker, Mairead, et al.
Publicado: (2022)

Prevalence of pemphigus and pemphigoid autoantibodies in the general population
por: Prüßmann, Wiebke, et al.
Publicado: (2015)

Recent advances in the understanding and treatment of pemphigus and pemphigoid
por: Yamagami, Jun
Publicado: (2018)

265 Evaluating the safety and effectiveness of the COVID-19 vaccination among pediatric atopic dermatitis patients
por: Pakhchanian, H., et al.
Publicado: (2022)

COVID-19 among patients with Behçet syndrome in the United States
por: Pakhchanian, Haig, et al.
Publicado: (2021)

35399 Examining the safety and efficacy of COVID-19 vaccination among atopic dermatitis patients
por: Pakhchanian, Haig, et al.
Publicado: (2022)

The risk of COVID-19 in patients with bullous pemphigoid and pemphigus: A population-based cohort study
por: Kridin, Khalaf, et al.
Publicado: (2021)

Pemphigus Vulgaris and Bullous Pemphigoid: Update on Diagnosis and Treatment
por: Di Lernia, Vito, et al.
Publicado: (2020)

Worldwide epidemiologic factors in pemphigus vulgaris and bullous pemphigoid
por: Rosi-Schumacher, Mattie, et al.
Publicado: (2023)

COVID-19 vaccination outcomes among patients with dermatomyositis: a multicentered analysis
por: Pakhchanian, Haig, et al.
Publicado: (2022)

Burden of Thrombotic Events in Coronavirus Disease-19 (COVID-19) Patients and Effect on Outcomes (from a Multicenter Electronic Health Record Database)
por: Mukherjee, Amrita, et al.
Publicado: (2021)

Bullous pemphigoid developed in a patient with chronic benign familial pemphigus
por: Hu, Yuqing, et al.
Publicado: (2022)

Dapsone in the Management of Pemphigus and Pemphigoid: Rediscovery of its Long-Lost Efficacy
por: Alkeraye, Salim, et al.
Publicado: (2020)

255 The risk of contracting COVID-19 after dermatological procedures compared with other medical procedures
por: Raiker, R., et al.
Publicado: (2021)

Alterations of Total Serum Immunoglobulin Concentrations in Pemphigus and Pemphigoid: Selected IgG2 Deficiency in Bullous Pemphigoid
por: Khil'chenko, Stanislav, et al.
Publicado: (2020)

A Scoping Review of the Role of Metalloproteinases in the Pathogenesis of Autoimmune Pemphigus and Pemphigoid
por: Cirillo, Nicola, et al.
Publicado: (2021)

Pemphigus and pemphigoid research by dermatologists and stomatologists: A scientometric and comparative study
por: Zhou, Shanxin, et al.
Publicado: (2023)

Outcomes of COVID-19 in patients with rheumatoid arthritis: A multicenter research network study in the United States
por: Raiker, Rahul, et al.
Publicado: (2021)

Nail changes in pemphigus and bullous pemphigoid: A single-center study in China
por: Cao, Shan, et al.
Publicado: (2022)

Bullous pemphigoid and pemphigus vulgaris—incidence and mortality in the UK: population based cohort study
por: Langan, S M, et al.
Publicado: (2008)

Axial spondyloarthritis may protect against poor outcomes in COVID-19: propensity score matched analysis of 9766 patients from a nationwide multi-centric research network
por: Raiker, Rahul, et al.
Publicado: (2021)

Perspective From the 5th International Pemphigus and Pemphigoid Foundation Scientific Conference
por: Lee, Jinmin, et al.
Publicado: (2018)

335 Trends in dermatological prescribing patterns during the COVID pandemic
por: Pakhchanian, H., et al.
Publicado: (2021)

332 National trends of dermatology procedures during the COVID pandemic
por: Raiker, R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kuaheidecetmoou7u2c2soaefi